ARCALIS will exhibit an exhibition booth at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Boston from May 11th to 15th, 2026. We warmly welcome conference attendees to visit our booth. 

【Event details】 

Official website:  Annual Meeting | ASGCT Annual Meeting 

Date:  May 11^th (Mon) -15^th (Fri), 2026 

Venue:  Thomas M. Menino Convention & Exhibition Center, Boston, USA 

Access: MCEC | Signature Boston 

【Abstract】 

ARCALIS offers fully integrated drug development services ranging from mRNA design to large-scale GMP manufacturing for safe and effective mRNA-based therapeutics. We will introduce the following proprietary technologies developed by ARCALIS that contribute to the manufacturing of high-quality mRNA therapeutics: 

1. An organ-selective mRNA delivery platform using lipid nanoparticles (LNPs) with optimized lipid compositions 

2. A proprietary saRNA platform for efficient and sustained protein expression 

3. An innovative codon optimization technology, “HARNA™,” based on an mRNA stability prediction model by machine learning 

4. A small-scale multiplex manufacturing platform suitable for screening mRNA drug candidates 

5. T7 RNA polymerase to minimize dsRNA impurities and reduce undesired immune responses